Δημοσίευση στις May 2019 στο PubMed: https://pubmed.ncbi.nlm.nih.gov/30739508/?from_term=tsioufis&from_sort=date&from_size=200&from_pos=50

 

Kornelia Kotseva 

 

, Guy De Backer 

 

, Dirk De Bacquer 

 

, Lars Rydén 

 

, Arno Hoes 

 

, Diederick Grobbee 

 

, Aldo Maggioni 

 

, Pedro Marques-Vidal 

 

, Catriona Jennings 

 

, Ana Abreu 

, Carlos Aguiar 

 
0
, Jolita Badariene 

 

, Jan Bruthans 

 

, Almudena Castro Conde 

, Renata Cifkova 

 

, Jim Crowley 

 

, Kairat Davletov 

, Jaap Deckers 

 

, Delphine De Smedt 

 

, Johan De Sutter 

 

 

, Mirza Dilic 

 
0
, Marina Dolzhenko 

, Vilnis Dzerve 

 

, Andrejs Erglis 

 

, Zlatko Fras 

 

 

, Dan Gaita 

 

, Nina Gotcheva 

, Peter Heuschmann 

 

 
0
, Hosam Hasan-Ali 

, Piotr Jankowski 

, Nebojsa Lalic 

, Seppo Lehto 

 

, Dragan Lovic 

 

, Silvia Mancas 

, Linda Mellbin 

 

, Davor Milicic 

 

, Erkin Mirrakhimov 

 

 

, Rafael Oganov 

, Nana Pogosova 
0
, Zeljko Reiner 

 

, Stefan Stöerk 
0
 

, Lâle Tokgözoğlu 

 

, Costas Tsioufis 

 

, Dusko Vulic 

, David Wood 

 

 

, EUROASPIRE Investigators*


Aims:

The aim of this study was to determine whether the Joint European Societies guidelines on secondary cardiovascular prevention are followed in everyday practice.


Design:

A cross-sectional ESC-EORP survey (EUROASPIRE V) at 131 centres in 81 regions in 27 countries.


Methods:

Patients (<80 years old) with verified coronary artery events or interventions were interviewed and examined ≥6 months later.


Results:

A total of 8261 patients (females 26%) were interviewed. Nineteen per cent smoked and 55% of them were persistent smokers, 38% were obese (body mass index ≥30 kg/m2), 59% were centrally obese (waist circumference: men ≥102 cm; women ≥88 cm) while 66% were physically active <30 min 5 times/week. Forty-two per cent had a blood pressure ≥140/90 mmHg (≥140/85 if diabetic), 71% had low-density lipoprotein cholesterol ≥1.8 mmol/L (≥70 mg/dL) and 29% reported having diabetes. Cardioprotective medication was: anti-platelets 93%, beta-blockers 81%, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers 75% and statins 80%.


Conclusion:

A large majority of coronary patients have unhealthy lifestyles in terms of smoking, diet and sedentary behaviour, which adversely impacts major cardiovascular risk factors. A majority did not achieve their blood pressure, low-density lipoprotein cholesterol and glucose targets. Cardiovascular prevention requires modern preventive cardiology programmes delivered by interdisciplinary teams of healthcare professionals addressing all aspects of lifestyle and risk factor management, in order to reduce the risk of recurrent cardiovascular events.


Keywords:

EUROASPIRE; cardiovascular risk factors; guidelines; lifestyle; secondary prevention.

error: